Intelicanna Stock Current Valuation
| INTL Stock | 56.00 1.80 3.11% |
Valuation analysis of Intelicanna helps investors to measure Intelicanna's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Intelicanna's price fluctuation is not too volatile at this time. Calculation of the real value of Intelicanna is based on 3 months time horizon. Increasing Intelicanna's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Intelicanna is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Intelicanna Stock. However, Intelicanna's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 56.0 | Real 49.37 | Hype 56.0 | Naive 45.14 |
The real value of Intelicanna Stock, also known as its intrinsic value, is the underlying worth of Intelicanna Company, which is reflected in its stock price. It is based on Intelicanna's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Intelicanna's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Intelicanna helps investors to forecast how Intelicanna stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Intelicanna more accurately as focusing exclusively on Intelicanna's fundamentals will not take into account other important factors: Intelicanna Company Current Valuation Analysis
Intelicanna's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Intelicanna Current Valuation | 64.57 M |
Most of Intelicanna's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intelicanna is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Intelicanna has a Current Valuation of 64.57 M. This is 99.55% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers-Specialty & Generic industry. The current valuation for all Israel stocks is 99.61% higher than that of the company.
Intelicanna Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intelicanna's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intelicanna could also be used in its relative valuation, which is a method of valuing Intelicanna by comparing valuation metrics of similar companies.Intelicanna is rated below average in current valuation category among its peers.
Intelicanna Fundamentals
| Return On Equity | -3.48 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (2.86) % | |||
| Current Valuation | 64.57 M | |||
| Shares Outstanding | 46.96 M | |||
| Shares Owned By Insiders | 34.65 % | |||
| Price To Sales | 4.14 X | |||
| Revenue | 4.21 M | |||
| Gross Profit | (9.19 M) | |||
| EBITDA | (10.67 M) | |||
| Net Income | (14.64 M) | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (15.38 M) | |||
| Earnings Per Share | (0.33) X | |||
| Number Of Employees | 40 | |||
| Beta | -0.89 | |||
| Market Capitalization | 17 M |
About Intelicanna Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intelicanna's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelicanna using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelicanna based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Intelicanna Stock
Intelicanna financial ratios help investors to determine whether Intelicanna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Intelicanna with respect to the benefits of owning Intelicanna security.